Effectiveness of medical and environmental interventions to reduce cystoscopy discomfort

Active Grant Awarded

Award ID
R01CA303719
Recipient
Awarding agency
Obligated
$594,869

Award facts

Assistance listing
93.394 Cancer Detection and Diagnosis Research
Completion date 4% complete
Place of performance
White River Junction, VT 05009, USA

Award details come from USAspending.gov.

About this award

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded Veterans Education And Research Association Of Northern New England, Inc. $594,869 on September 17, 2026, under Assistance Listing 93.394, Cancer Detection and Diagnosis Research, through Grant R01CA303719. The recipient will conduct a factorial pragmatic hybrid Type 1 effectiveness-implementation trial, including 570 women, to reduce discomfort during office cystoscopy, a procedure used for bladder cancer diagnosis and surveillance. The trial compares patient-reported outcomes across patients receiving evidence-based discomfort-reduction interventions, determines which interventions reduce discomfort for specific patient subgroups, and assesses implementation challenges and strategies for successful interventions. The period of performance ends August 31, 2031, and work is performed at White River Junction, VT 05009. The federal program funds research to improve screening and early detection strategies and to develop accurate diagnostic techniques for cancer.

Description

Abstract
Each year, over a million americans undergo office cystoscopy for bladder cancer diagnosis and surveillance, an invasive procedure which involves visual inspection of the bladder through an endoscope passed through the urethra without general anesthesia. About one-third of patients experience major discomfort during office cystoscopy, and over 40% of bladder cancer patients have substantial anxiety associated with the procedure. Discomfort can be alleviated with intraurethral lidocaine, which is routinely used in practice. However, dwell times are not standardized, and IT is unclear whether dwell times >10 minutes are more effective than short dwell times of 5-10 minutes. Listening to music is efficacious but not routinely used. Watching the procedure on a screen ("visualization") is efficacious and routinely used more than two thirds of the time. A systematic review performed by our team showed that there is a critical GAP in the evidence regarding which of these interventions are most effective and for whom they work best, as they never have been evaluated in an adequately powered effectiveness trial. Reducing discomfort with cystoscopy was ranked as the highest area of importance among topics with available efficacy data by our bladder cancer advocacy network patient survey network, in which patients across the united states prioritized research topics. Our study will address this GAP by 1) comparing patient-reported outcomes between patients undergoing evidence-based interventions to reduce cystoscopy discomfort; 2) determining which interventions reduce cystoscopy discomfort for specific patient subgroups; and 3) assessing implementation challenges during the trial and specifying strategies to implement successful interventions. To achieve these aims, we will perform a factorial pragmatic hybrid type 1 effectiveness-implementation trial, including 570 women and 1,170 men undergoing 850 and 1,750 cystoscopy procedures, respectively, across seven clinical sites. Participants will be randomized to intraurethral lidocaine with short (5-10 min) VS. Long dwell time (>10 min) and to listening or not listening to music. Randomization will be stratified based on participants choosing visualization or not, prior cystoscopy experience (cysto-experienced VS. Cysto-naïve), SEX, and site. We will measure pain following each cystoscopy on a visual analog scale (range 0-10) as our primary outcome. We will use mixed methods to identify implementation challenges during the start-up phase and processes to maintain fidelity throughout the trial. Defining the comparative effectiveness of patient-centered evidence-based interventions to reduce cystoscopy discomfort will help millions of americans who undergo office cystoscopy tolerate this invasive procedure, reduce anxiety, and increase adherence. At the end of this study, we will know which interventions are effective for whom and provide a blueprint for how to best implement them in various practice settings.

Quick answers

Who received award R01CA303719?

R01CA303719 was awarded to Veterans Education And Research Association Of Northern New England, Inc. by National Cancer Institute (National Institutes of Health) on September 17, 2026.

How much is award R01CA303719 worth?

$594,869 has been obligated on R01CA303719.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award